Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tolnaftate 1% liquid spray
1310020Y0AAAPAP
|
Tolnaftate | Tolnaftate | Skin | 38 |
|
Tolnaftate 1% powder
1310020Y0AAABAB
|
Tolnaftate | Tolnaftate | Skin | 1 |
|
Tolnaftate 0.12% spray
1310020Y0AAAKAK
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Benzalkonium chloride 0.1% cream
1310020Y0AAALAL
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Benzalkonium chloride 0.1% ointment
1310020Y0AAAGAG
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Chlorhexidine 0.25% powder
1310020Y0AAAHAH
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% cream
1310020Y0AAAAAA
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% dry powder spray
1310020Y0AAAJAJ
|
Tolnaftate | Tolnaftate | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.